Center for Surgical Science, Department of Surgery, Zealand University Hospital, Koege, Denmark.
Department of Surgery, Slagelse Hospital, Slagelse, Denmark.
BJS Open. 2021 May 7;5(3). doi: 10.1093/bjsopen/zrab023.
Personalized risk assessment provides opportunities for tailoring treatment, optimizing healthcare resources and improving outcome. The aim of this study was to develop a 90-day mortality-risk prediction model for identification of high- and low-risk patients undergoing surgery for colorectal cancer.
This was a nationwide cohort study using records from the Danish Colorectal Cancer Group database that included all patients undergoing surgery for colorectal cancer between 1 January 2004 and 31 December 2015. A least absolute shrinkage and selection operator logistic regression prediction model was developed using 121 pre- and intraoperative variables and internally validated in a hold-out test data set. The accuracy of the model was assessed in terms of discrimination and calibration.
In total, 49 607 patients were registered in the database. After exclusion of 16 680 individuals, 32 927 patients were included in the analysis. Overall, 1754 (5.3 per cent) deaths were recorded. Targeting high-risk individuals, the model identified 5.5 per cent of all patients facing a risk of 90-day mortality exceeding 35 per cent, corresponding to a 6.7 times greater risk than the average population. Targeting low-risk individuals, the model identified 20.9 per cent of patients facing a risk less than 0.3 per cent, corresponding to a 17.7 times lower risk compared with the average population. The model exhibited discriminatory power with an area under the receiver operating characteristics curve of 85.3 per cent (95 per cent c.i. 83.6 to 87.0) and excellent calibration with a Brier score of 0.04 and 32 per cent average precision.
Pre- and intraoperative data, as captured in national health registries, can be used to predict 90-day mortality accurately after colorectal cancer surgery.
个性化风险评估为调整治疗方案、优化医疗资源和改善预后提供了机会。本研究旨在建立一种用于识别结直肠癌手术患者的高风险和低风险人群的 90 天死亡率风险预测模型。
这是一项全国性队列研究,使用丹麦结直肠癌组数据库中的记录,纳入了 2004 年 1 月 1 日至 2015 年 12 月 31 日期间接受结直肠癌手术的所有患者。采用 121 个术前和术中变量,通过最小绝对收缩和选择算子逻辑回归预测模型进行构建,并在保留的测试数据集内部验证。通过区分度和校准度评估模型的准确性。
数据库中共登记了 49607 例患者。排除 16680 例患者后,共纳入 32927 例患者进行分析。共记录了 1754 例(5.3%)死亡。该模型确定了 5.5%的所有患者存在 90 天死亡率超过 35%的高风险,风险比普通人群高 6.7 倍。针对低风险患者,模型确定了 20.9%的患者存在 90 天死亡率低于 0.3%的低风险,风险比普通人群低 17.7 倍。该模型具有较高的区分度,接受者操作特征曲线下面积为 85.3%(95%置信区间 83.6%至 87.0%),校准度良好,Brier 评分为 0.04,平均精度为 32%。
从国家健康登记处获取的术前和术中数据可准确预测结直肠癌手术后 90 天的死亡率。